These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Interactions between aluminum and the actions and metabolism of vitamin D3 in the chick. Henry HL; Norman AW Calcif Tissue Int; 1985 Sep; 37(5):484-90. PubMed ID: 2998576 [TBL] [Abstract][Full Text] [Related]
23. Inhibitory and stimulatory effects of dexamethasone and 1,25-dihydroxyvitamin D3 on chick intestinal calbindin-D28K and its mRNA. Hall AK; Bishop JE; Norman AW Mol Cell Endocrinol; 1987 May; 51(1-2):25-31. PubMed ID: 3036623 [TBL] [Abstract][Full Text] [Related]
24. Biologic activity of dihydroxylated 19-nor-(pre)vitamin D3. Bouillon R; Sarandeses LA; Allewaert K; Zhao J; MascareƱas JL; MouriƱo A; Vrielynck S; de Clercq P; Vandewalle M J Bone Miner Res; 1993 Aug; 8(8):1009-15. PubMed ID: 8213251 [TBL] [Abstract][Full Text] [Related]
25. Biological activity of 1,25-dihydroxyvitamin D2 and 24-epi-1,25-dihydroxyvitamin D2. DeLuca HF; Sicinski RR; Tanaka Y; Stern PH; Smith CM Am J Physiol; 1988 Apr; 254(4 Pt 1):E402-6. PubMed ID: 2833108 [TBL] [Abstract][Full Text] [Related]
26. Trypsin cleavage of chick 1,25-dihydroxyvitamin D3 receptors. Generation of discrete polypeptides which retain hormone but are unreactive to DNA and monoclonal antibody. Allegretto EA; Pike JW J Biol Chem; 1985 Aug; 260(18):10139-45. PubMed ID: 2410420 [TBL] [Abstract][Full Text] [Related]
27. Binding properties of plasma vitamin D-binding protein and intestinal 1,25-dihydroxyvitamin D3 receptor in piglets with pseudo-vitamin D-deficiency rickets, type I: treatment effects with pharmacological doses of vitamin D3. Kaune R; Schroeder B; Harmeyer J Arch Biochem Biophys; 1990 Nov; 282(2):326-32. PubMed ID: 2173481 [TBL] [Abstract][Full Text] [Related]
28. The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine. Brown AJ; Finch J; Grieff M; Ritter C; Kubodera N; Nishii Y; Slatopolsky E Endocrinology; 1993 Sep; 133(3):1158-64. PubMed ID: 8396012 [TBL] [Abstract][Full Text] [Related]
29. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
30. The biological assessment of vitamin D3 metabolites produced by rumen bacteria. Gardner RM; Reinhardt TA; Horst RL J Steroid Biochem; 1988 Feb; 29(2):185-9. PubMed ID: 2831435 [TBL] [Abstract][Full Text] [Related]
31. Regulatory activities of 2 beta-(3-hydroxypropoxy)-1 alpha, 25-dihydroxyvitamin D3, a novel synthetic vitamin D3 derivative, on calcium metabolism. Okano T; Tsugawa N; Masuda S; Takeuchi A; Kobayashi T; Takita Y; Nishii Y Biochem Biophys Res Commun; 1989 Sep; 163(3):1444-9. PubMed ID: 2551289 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological activity of vitamin D3 analogues. Ikekawa N J Steroid Biochem; 1983 Jul; 19(1C):907-11. PubMed ID: 6310260 [TBL] [Abstract][Full Text] [Related]
33. Biological activity assessment of 1 alpha,25-dihydroxyvitamin D3-26,23-lactone and its intermediate metabolites in vivo and in vitro. Ishizuka S; Sumitani K; Hiura K; Kawata T; Okawa M; Hakeda Y; Kumegawa M Endocrinology; 1990 Aug; 127(2):695-701. PubMed ID: 2373050 [TBL] [Abstract][Full Text] [Related]
34. Fluoride substitution of vitamin D analogs at C-26 and C-27: enhancement of activity of 25-hydroxyvitamin D but not of 1,25-dihydroxyvitamin D on bone and intestine in vitro. Stern PH; Mavreas T; Tanaka Y; DeLuca HF; Ikekawa N; Kobayashi Y J Pharmacol Exp Ther; 1984 Apr; 229(1):9-13. PubMed ID: 6323693 [TBL] [Abstract][Full Text] [Related]
35. Unoccupied and in vitro and in vivo occupied 1,25-dihydroxyvitamin D3 intestinal receptors. Multiple biochemical forms and evidence for transformation. Hunziker W; Walters MR; Bishop JE; Norman AW J Biol Chem; 1983 Jul; 258(14):8642-8. PubMed ID: 6305995 [TBL] [Abstract][Full Text] [Related]
36. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3. Skowronski RJ; Peehl DM; Feldman D Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193 [TBL] [Abstract][Full Text] [Related]
37. Regulation of 1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells. Costa EM; Hirst MA; Feldman D Endocrinology; 1985 Nov; 117(5):2203-10. PubMed ID: 2995009 [TBL] [Abstract][Full Text] [Related]
38. 1,25-Dihydroxyvitamin D3-mediated vesicular transport of calcium in intestine: time-course studies. Nemere I; Norman AW Endocrinology; 1988 Jun; 122(6):2962-9. PubMed ID: 3371269 [TBL] [Abstract][Full Text] [Related]
39. 1 alpha,25-dihydroxyvitamin D3 receptors and their action in embryonic chick chondrocytes. Suda S; Takahashi N; Shinki T; Horiuchi N; Yamaguchi A; Yoshiki S; Enomoto S; Suda T Calcif Tissue Int; 1985 Jan; 37(1):82-90. PubMed ID: 2986803 [TBL] [Abstract][Full Text] [Related]
40. Comparison of calcipotriol with selected metabolites and analogues of vitamin D3: effects on cell growth regulation in vitro and calcium metabolism in vivo. Binderup L Pharmacol Toxicol; 1993; 72(4-5):240-4. PubMed ID: 8396769 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]